A higher proportion of patients with NAFLD and a high risk of fibrosis according to LSM had diabetes mellitus, BMI over 30 kg/m2, ALT over 33 UI, and ERS over 16 mm, compared to patients with a low risk of fibrosis (Supplementary Table S4). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.